Trial · NCT03659916
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period (72 Weeks) | STARTED | Cohort 1: Placebo/Odevixibat | 19 | |
| Treatment Period (72 Weeks) | STARTED | Cohort 1: Odevixibat/Odevixibat | 37 | |
| Treatment Period (72 Weeks) | STARTED | Cohort 2: Odevixibat | 60 | |
| Treatment Period (72 Weeks) | COMPLETED | Cohort 1: Placebo/Odevixibat | 15 | |
| Treatment Period (72 Weeks) | COMPLETED | Cohort 1: Odevixibat/Odevixibat | 28 | |
| Treatment Period (72 Weeks) | COMPLETED | Cohort 2: Odevixibat | 40 | |
| Treatment Period (72 Weeks) | NOT COMPLETED | Cohort 1: Placebo/Odevixibat | 4 | |
| Treatment Period (72 Weeks) | NOT COMPLETED | Cohort 1: Odevixibat/Odevixibat | 9 | |
| Treatment Period (72 Weeks) | NOT COMPLETED | Cohort 2: Odevixibat | 20 | |
| Optional Extension Treatment (176 Weeks) | STARTED | Cohort 1: Placebo/Odevixibat | 14 | |
| Optional Extension Treatment (176 Weeks) | STARTED | Cohort 1: Odevixibat/Odevixibat | 27 | |
| Optional Extension Treatment (176 Weeks) | STARTED | Cohort 2: Odevixibat | 33 | |
| Optional Extension Treatment (176 Weeks) | COMPLETED | Cohort 1: Placebo/Odevixibat | 0 | |
| Optional Extension Treatment (176 Weeks) | COMPLETED | Cohort 1: Odevixibat/Odevixibat | 0 | |
| Optional Extension Treatment (176 Weeks) | COMPLETED | Cohort 2: Odevixibat | 0 | |
| Optional Extension Treatment (176 Weeks) | NOT COMPLETED | Cohort 1: Placebo/Odevixibat | 14 | |
| Optional Extension Treatment (176 Weeks) | NOT COMPLETED | Cohort 1: Odevixibat/Odevixibat | 27 | |
| Optional Extension Treatment (176 Weeks) | NOT COMPLETED | Cohort 2: Odevixibat | 33 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03659916/flow